about
Mad-related genes in the humanHypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorderOncogenic forms of p53 inhibit p53-regulated gene expression14-3-3sigma is a p53-regulated inhibitor of G2/M progressionA cascade of modules of a network defines cancer progressionPAK1, a gene that can regulate p53 activity in yeast.Histone deacetylases: unique players in shaping the epigenetic histone code.Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence.Sequence-specific transcriptional activation is essential for growth suppression by p53.ATPase activity of the UvrA and UvrAB protein complexes of the Escherichia coli UvrABC endonucleaseEpigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics.Elucidation of epigenetic inactivation of SMAD8 in cancer using targeted expressed gene display.Homeosis and polyposis: a tale from the mouse.Molecular detection of smad2/smad4 alterations in colorectal tumors.Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.Epigenetic alterations of the dopaminergic system in major psychiatric disorders.Frequency of Smad gene mutations in human cancers.DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder.Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancersAberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progressionCan the schizophrenia epigenome provide clues for the molecular basis of pathogenesis?Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to IrinotecanMicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancerAberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder
P50
Q24328786-4BDA0BF6-4C7B-4E29-BBDA-F34C898F3AF2Q24652360-08B14FAA-B630-4B26-93E7-E216A4E321B3Q28251120-DE878BAB-C351-4787-98A7-09701AA0AC17Q28276061-A9E18F7E-D1D5-42DF-AC03-E9ABFF015B3AQ33574838-FA61B793-EA28-4B0E-A36D-9D09DD5ACC9DQ34181807-D26D8303-5419-4E7E-8E8A-48D7B2AF61D5Q34193936-140EF5EA-0A64-4470-B45B-1E4B343991BFQ34395443-3F3636BD-8384-4F6C-A7FD-5EE23E3CF9E5Q34493845-8A636CCC-A39B-41D2-8AFB-432A4075071BQ35086763-4DE1C6F8-AF13-479B-B5EA-E7940910723FQ35229723-5B5234AE-13FE-4543-A767-830BD63E0C9AQ37346195-EEDF27FE-5CE5-4E1A-8F94-C529C6F836A3Q40583219-910F3D47-DE81-4C28-83AF-71908958FBBEQ41538516-1CE7EA68-9380-4287-8754-1C32597775DFQ42750829-07C3F16C-6CA6-495D-AEEA-13A0A88C1CBFQ45345221-9C7765AA-2FE4-410C-8463-6CDB98B34A2AQ46679617-9EBB4084-0E00-4439-9FF5-25551B23798AQ48676822-75E333B8-1D58-4F57-9E30-E0CA4935510CQ48960452-EB4A06C5-BCF8-4600-8112-D1277D18B939Q50801652-7D4C6B09-33EB-436B-84BB-FC07E589597CQ51035222-BEC67353-A446-4164-98CA-E5C6E32AADE2Q71167724-14542105-B8A0-4CDD-88FA-FE85954DE27AQ80621765-3B10FEBE-91B0-4844-BD9D-DC61058CF10BQ82726275-022CFA55-FDFE-42EC-BA4C-5B09ACC275E4Q92608876-E29E7F9F-5895-40A7-8ECB-26734BA7289BQ92680791-AE9E7009-CEF1-4ADB-95F8-19F6A06766CBQ93368329-23F61ED3-C3D9-485D-BECF-697C9306A322
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sam Thiagalingam
@ast
Sam Thiagalingam
@en
Sam Thiagalingam
@es
Sam Thiagalingam
@nl
Sam Thiagalingam
@sl
type
label
Sam Thiagalingam
@ast
Sam Thiagalingam
@en
Sam Thiagalingam
@es
Sam Thiagalingam
@nl
Sam Thiagalingam
@sl
prefLabel
Sam Thiagalingam
@ast
Sam Thiagalingam
@en
Sam Thiagalingam
@es
Sam Thiagalingam
@nl
Sam Thiagalingam
@sl
P106
P21
P31
P496
0000-0001-5211-266X